Mirion Technologies, Inc. is a global leader in radiation safety, science, and medicine, providing innovative solutions that protect people and the planet from the harmful effects of ionizing radiation. The company offers a diverse portfolio of products and services that support advancements in various sectors, including nuclear energy, defense, healthcare, and scientific research.
Established between 1950 and 2004 through the consolidation of innovators and manufacturers in radiation solutions and services for industrial markets, Mirion was officially incorporated in December 2005. The company is headquartered in Atlanta, Georgia, USA, and operates globally, serving customers in North America, Europe, and the Asia Pacific .
Mirion operates through two primary segments: Medical and Nuclear & Safety. The Medical segment provides radiation oncology quality assurance and dosimetry solutions, patient safety solutions for diagnostic imaging and radiation therapy centers, radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy, and radionuclide therapy products for nuclear medicine applications. The Nuclear & Safety segment offers radiation detection, measurement, analysis, and monitoring products and services for nuclear power, military and civil defense, and medical industries .
The company's mission is to deliver innovative radiation detection, measurement, analysis, and monitoring solutions that enhance the safety, security, and efficiency of its customers' operations. Mirion is committed to providing exceptional value to customers through reliable products, expert services, and a dedication to continuous improvement .
Mirion Technologies is publicly traded on the New York Stock Exchange under the ticker symbol "MIR" .
CdZnTe Association (CdZnTe.com)
https://www.cdznte.com/organization/mirion-technologies.html
